Trials / Unknown
UnknownNCT04890184
Grape Juice and Dermatitis in Breast Cancer
The Effect of Grape Juice Consumption on Radiotherapy-induced Dermatitis in Breast Cancer - A Pilot Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- National Nutrition and Food Technology Institute · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to investigate the effect of grape juice on acute radiation dermatitis in breast cancer (BC) patients undergoing radiotherapy (RT). 50 eligible BC patients will randomly assign to consume 100 gr of grape juice per day during and 1 week after RT or with no intervention (control group). The radiation dermatitis will be assessed weekly according to the Radiation Therapy Oncology Group/ European Organization for Research and Treatment of Cancer (RTOG/EORTC) scales.
Detailed description
Dietary intake of patients will be examined by expert dietitians at baseline and end of RT using the average of three-day 24-hour recalls. Weight (kg), body fat percentage, skeletal muscle percentage and visceral fat level will be measured using the OMRON Body Composition Monitor and Scale.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | grape juice | grape juice |
| OTHER | control | no intervention |
Timeline
- Start date
- 2021-05-08
- Primary completion
- 2021-07-01
- Completion
- 2021-07-15
- First posted
- 2021-05-18
- Last updated
- 2021-05-18
Source: ClinicalTrials.gov record NCT04890184. Inclusion in this directory is not an endorsement.